The Hospital Rethinkers

Interview with Dr. Axel Paeger, Founder and Partner of the AMEOS Group, Zurich

AMEOS Group Dialogue with Politics
In dialogue with politics: AMEOS is restructuring hospitals, optimizing processes, and focusing on the well-being of patients. Dr. Axel Paeger in conversation with the Prime Minister of Mecklenburg-Western Pomerania, Ms. Manuela Schwesig

The economic situation of numerous hospitals in Germany is tense. Rising operational costs, acute staff shortages, inadequate funding from health insurance companies, and the introduction of case flat rates are putting many hospitals under pressure. The AMEOS Group from Zurich is familiar with this situation. It is one of the most important health care providers in the German-speaking area and consistently focuses on health.

The situation is serious. Hospitals are being closed for purely economic reasons, others are in bankruptcy proceedings, and no buyers are in sight. Over the past years, AMEOS has saved many hospitals and repositioned them for the future.

Healthcare as Patient

Dr. Axel Paeger founded AMEOS in 2002 in Zurich. "After years of working as a doctor in hospitals, I knew the challenges from my own experience," he says. "In starting the company, I saw the opportunity to operate my own hospitals, thereby improving processes and ensuring regional supply." Since its founding, many things have changed. Among other things, flat-rate case payments, the so-called DRGs, were introduced; hospital services are thus billed per case rather than by days spent in the hospital. The consequence: hospitals that previously operated inefficiently faced difficulties. "In this time, our experience and expertise were highly sought after," says Dr. Axel Paeger.

"We have taken over many hospitals and positioned them in a way that they provide good services. As a result, we grew more than originally planned. Despite challenging conditions, we want to continue this growth. In the hospital sector in Germany, we face a unique situation where the cost side operates according to market economics, while the pricing side is politically set. This led to a discrepancy of 13% in the last two and a half years. In the past, we have taken over many hospitals in bankruptcy, but under current conditions, such acquisitions are no longer realistic, as insolvent hospitals can no longer be rehabilitated due to the lack of compensation adjustments."

Opportunities in Change

Today, AMEOS employs 18,400 staff and generates a turnover of 1.4 billion EUR. The group includes more than 54 hospitals in the DACH region; at each location, the focus is on the individual and their health. Continuous improvement of patient care and increasing efficiency remain central goals for AMEOS in the future. "In the past 18 months, we have successfully implemented 140 restructuring projects," says Dr. Axel Paeger.

"We are evaluating how many locations actually need certain specialties. This way, we have significantly reduced duplicate or redundant provisions without compromising the quality of patient care. Our problem is the 13% gap between costs and prices; this is a bigger challenge for us than the shortage of skilled workers, since we largely train our staff ourselves. I believe that hospitals must transform into competitive, high-performance health centers to ensure long-term, high-level patient care."

More Articles on Topic

Gold Is Not a Relic – It Is an Anchor of Security

Interview with Kálmán Schmidt, Managing Director of Magyar Aranypiac Kft.

Gold Is Not a Relic – It Is an Anchor of Security

The gold market has been enjoying a notable renaissance for several years.

For the Physical Well-being

Interview with Nicole Stein, Managing Director of Melles & Stein Messe-Service GmbH

For the Physical Well-being

As an innovative and reliable partner for culinary and staffing trade fair support, Melles & Stein Messe-Service GmbH...

Supply-Chain-as-a-Service for Specialty Pharmaceuticals

Interview with Christoph Staub, CEO of Allpack Group AG

Supply-Chain-as-a-Service for Specialty Pharmaceuticals

While mass-produced medications such as over-the-counter pain relievers are manufactured and distributed in the millions, the business of orphan drugs...

Innovative Testing Solutions for a Healthier Future

Interview with Dr. Lothar Kruska, Managing Director of Seegene Germany GmbH

Innovative Testing Solutions for a Healthier Future

Seegene Germany GmbH, based in Düsseldorf, specializes in the development of innovative testing solutions in the field of molecular diagnostics.

Manfred Brinkmann, Managing Editor-in-Chief

Manfred Brinkmann

Managing Editor of European Business

Are You Shaping the Future of Business?

As Managing Editor-in-Chief, I am always searching for the next generation of leaders and innovators. If you are at the helm of a company making a significant impact, I invite you to connect with us. Let's share your vision with our audience of influentia.